Vandana Batra, MBBS,MD
Assistant Professor of Clinical Pediatrics (Oncology)
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
The HUB for Clinical Collaboration
Office 3526, Third Floor
3500 Civic Center Boulevard
Philadelphia, PA 19104
The HUB for Clinical Collaboration
Office 3526, Third Floor
3500 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-226-7360
Email:
BATRAV@chop.edu
BATRAV@chop.edu
Education:
MBBS
Lady Hardinge Medical College (LHMC), New Delhi, India, 1992.
MD (Pediatrics)
Maulana Azad Medical College (MAMC), New Delhi, India, 1996.
Permanent linkMBBS
Lady Hardinge Medical College (LHMC), New Delhi, India, 1992.
MD (Pediatrics)
Maulana Azad Medical College (MAMC), New Delhi, India, 1996.
Description of Clinical Expertise
Germ Cell TumorsDesmoid Fibromatosis
Neuroblastoma
Solid Tumors
Description of Other Expertise
Quality Improvement in Pediatric OncologyDescription of Research Expertise
Targeted RadiotherapySelected Publications
Batra V, Gikandi A, Pawel B, Martinez D, Granger MM, Marachelian A, Park JR, Maris JM, Vo KT, Matthay KK, DuBois SG. : Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma. Pediatric Blood and Cancer. Oct 2023 Notes: DOI: 10.1002/pbc.30743 Online ahead of print.Christine Hill-Kayser, Goldie Kurtz, Naomi Balamuth, Robert Lustig, Frank Balis, Suzanne Macfarland, Vandana Batra, Yael P. Mosse, John M. Maris, Sogol Mostoufi-Moab, Jill Ginsberg, Rochelle Bagatell: Efficacy & Toxicity of External Beam Radiotherapy (EBRT) for Metastatic Sites (MS) in Patients with High-Risk Neuroblastoma (HR-NBL). International Society of Pediatric Oncology, 55th Annual Congress, Ottawa, Canada Oct 2023 Notes: Poster.
Hill-Kayser CE, Li Y, Kurtz G, Mattei P, Balis F, Lustig RA, LaRiviere M, MacFarland S, Batra V, Mosse Y, Maris JM, Balamuth N, Bagatell R: Survival and local recurrence risk in patients with high-risk neuroblastoma treated with proton therapy over a 10 year interval. American Society for Radiation Oncology Annual Meeting, San Diego, CA Oct 2023 Notes: Poster
Kaoru Takasaki MD, Laura A.T. Kagami MD, Collen Croy PharmD, Jason L. Freedman MD, MSCE, Benjamin L. Laskin MD, Bridget Rauch BA, Anne Reilly MD, David H. Rhodes BSN, RN, Jennifer Stundon MD, PhD, Julie Vardaro MHA, Vandana Batra, MD: Improving guideline-concordant care for tumor lysis syndrome in pediatric oncology patients. American Society of Pediatric Hematology/Oncology Annual Conference, Fort Worth, TX May 2023 Notes: Poster
Micky K. Bacchus, BS; David S. Anderson, MD; Esther R. Berko, MD, PhD; Lisa J. States, MD; Rochelle Bagatell, MD; Sarah E. Hopkins, MD, MSPH; Vandana Batra, MD.: Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments. Journal of Pediatric Hematology/Oncology 45(3): 152-154, April 2023 Notes: DOI: 10.1097/MPH.0000000000002643.
Mehran Makvandi, Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel, David Groff, Jennifer Pogoriler, Daniel Martinez, Aladdin Riad, Hannah Dabagian, Michael Zaleski, Tara Taghvaee, Kuiying Xu, Ji Youn Lee, Catherine Hou, Alvin Farrel, Vandana Batra, Sean D. Carlin, Daniel J. Powell Jr, Robert H. Mach, Daniel A. Pryma & John M. Maris : Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma. Communications Biology 5(1): 1260, Nov 2022.
Batra V, Samanta M, Makvandi M, Groff D, Martorano P, Elias J, Ranieri P, Tsang M, Hou C, Li Y, Pawel B, Martinez D, Vaidyanathan G, Carlin S, Pryma DA, Maris JM.: Preclinical development of [211At]meta-astatobenzylguanidine ([211At]MABG) as an alpha particle radiopharmaceutical therapy for neuroblastoma. Clinical Cancer Research 28(18): 4146-4157, Sep 2022.
Batra V: Meta-[211At]astatobenzylguanidine ([211At]MABG) increases overall survival in a preclinical model of disseminated neuroblastoma. Advances in Neuroblastoma Research Conference, Virtual Jan 2021 Notes: Digital Poster.
Samanta M, Makvandi M, Groff D, Martorano P, Lee H, Batra V, Carlin S, Martinez D, Pogoriler J, Mach R, Pryma D, Maris J : The astatine-labeled PARP inhibitor [211At]MM4 induces complete and durable responses in neuroblastoma patient derived xenograft (PDX) models. Advances in Neuroblastoma Research Conference, Virtual Jan 2021 Notes: Digital Podium.
Ding Yang-Yang, Ramakrishna Sneha, Long Adrienne, Phillips Charles, Esparza Raul, Diorio Caroline, Aplenc Richard,Maude Shannon,Bailey Charles,Reilly Anne, Batra Vandana, Rheingold Susan, Lacayo Norman, Sakamoto Kathleen, Hunger Stephen : Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic. Pediatric Blood and Cancer 67(9): e28427, Sep 2020.